WO2008067291A3 - Method and apparatus for managing glucose control - Google Patents

Method and apparatus for managing glucose control Download PDF

Info

Publication number
WO2008067291A3
WO2008067291A3 PCT/US2007/085605 US2007085605W WO2008067291A3 WO 2008067291 A3 WO2008067291 A3 WO 2008067291A3 US 2007085605 W US2007085605 W US 2007085605W WO 2008067291 A3 WO2008067291 A3 WO 2008067291A3
Authority
WO
WIPO (PCT)
Prior art keywords
glucose control
managing glucose
managing
trends
apparatuses
Prior art date
Application number
PCT/US2007/085605
Other languages
French (fr)
Other versions
WO2008067291A2 (en
Inventor
William Kenneth Ward
Richard Sass
Robert Bruce
Original Assignee
Isense Corp
William Kenneth Ward
Richard Sass
Robert Bruce
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Isense Corp, William Kenneth Ward, Richard Sass, Robert Bruce filed Critical Isense Corp
Priority to JP2009539439A priority Critical patent/JP2010510866A/en
Priority to EP07868857.9A priority patent/EP2087356A4/en
Priority to CA002670414A priority patent/CA2670414A1/en
Publication of WO2008067291A2 publication Critical patent/WO2008067291A2/en
Publication of WO2008067291A3 publication Critical patent/WO2008067291A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4833—Assessment of subject's compliance to treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/74—Details of notification to user or communication with user or patient ; user input means
    • A61B5/7475—User input or interface means, e.g. keyboard, pointing device, joystick
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14503—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors

Abstract

Embodiments of the present invention provide methods, apparatuses, and systems associated with detecting, analyzing, and/or displaying historical glucose levels and/or trends in a body.
PCT/US2007/085605 2006-11-28 2007-11-27 Method and apparatus for managing glucose control WO2008067291A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2009539439A JP2010510866A (en) 2006-11-28 2007-11-27 Method and apparatus for managing glucose control
EP07868857.9A EP2087356A4 (en) 2006-11-28 2007-11-27 Method and apparatus for managing glucose control
CA002670414A CA2670414A1 (en) 2006-11-28 2007-11-27 Method and apparatus for managing glucose control

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US86750706P 2006-11-28 2006-11-28
US60/867,507 2006-11-28
US11/689,745 2007-03-22
US11/689,745 US8079955B2 (en) 2006-11-28 2007-03-22 Method and apparatus for managing glucose control

Publications (2)

Publication Number Publication Date
WO2008067291A2 WO2008067291A2 (en) 2008-06-05
WO2008067291A3 true WO2008067291A3 (en) 2008-07-24

Family

ID=39464546

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/085605 WO2008067291A2 (en) 2006-11-28 2007-11-27 Method and apparatus for managing glucose control

Country Status (5)

Country Link
US (1) US8079955B2 (en)
EP (1) EP2087356A4 (en)
JP (1) JP2010510866A (en)
CA (1) CA2670414A1 (en)
WO (1) WO2008067291A2 (en)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2572455C (en) 2004-06-04 2014-10-28 Therasense, Inc. Diabetes care host-client architecture and data management system
US8029441B2 (en) 2006-02-28 2011-10-04 Abbott Diabetes Care Inc. Analyte sensor transmitter unit configuration for a data monitoring and management system
US7736310B2 (en) 2006-01-30 2010-06-15 Abbott Diabetes Care Inc. On-body medical device securement
US8160900B2 (en) 2007-06-29 2012-04-17 Abbott Diabetes Care Inc. Analyte monitoring and management device and method to analyze the frequency of user interaction with the device
CA2715628A1 (en) 2008-02-21 2009-08-27 Dexcom, Inc. Systems and methods for processing, transmitting and displaying sensor data
WO2009146445A1 (en) * 2008-05-30 2009-12-03 Abbott Diabetes Care Inc. Method and system for providing glycemic control
US8924159B2 (en) 2008-05-30 2014-12-30 Abbott Diabetes Care Inc. Method and apparatus for providing glycemic control
US8591410B2 (en) 2008-05-30 2013-11-26 Abbott Diabetes Care Inc. Method and apparatus for providing glycemic control
WO2010009172A1 (en) 2008-07-14 2010-01-21 Abbott Diabetes Care Inc. Closed loop control system interface and methods
US8849458B2 (en) * 2008-12-23 2014-09-30 Roche Diagnostics Operations, Inc. Collection device with selective display of test results, method and computer program product thereof
US20120011125A1 (en) 2008-12-23 2012-01-12 Roche Diagnostics Operations, Inc. Management method and system for implementation, execution, data collection, and data analysis of a structured collection procedure which runs on a collection device
US10456036B2 (en) * 2008-12-23 2019-10-29 Roche Diabetes Care, Inc. Structured tailoring
US10437962B2 (en) 2008-12-23 2019-10-08 Roche Diabetes Care Inc Status reporting of a structured collection procedure
US9918635B2 (en) 2008-12-23 2018-03-20 Roche Diabetes Care, Inc. Systems and methods for optimizing insulin dosage
US9117015B2 (en) 2008-12-23 2015-08-25 Roche Diagnostics Operations, Inc. Management method and system for implementation, execution, data collection, and data analysis of a structured collection procedure which runs on a collection device
CN102265280A (en) 2008-12-23 2011-11-30 霍夫曼-拉罗奇有限公司 Management method and system for implementation, execution, data collection, and data analysis of a structured collection procedure which runs on a collection device
US20100168539A1 (en) * 2008-12-31 2010-07-01 Palerm Cesar C Method and/or system for estimating glycation of hemoglobin
EP2410910A4 (en) * 2009-03-27 2014-10-15 Dexcom Inc Methods and systems for promoting glucose management
EP2425209A4 (en) 2009-04-29 2013-01-09 Abbott Diabetes Care Inc Method and system for providing real time analyte sensor calibration with retrospective backfill
US20110196213A1 (en) * 2009-06-26 2011-08-11 Roche Diagnostics Operations, Inc. Display For Biological Values
JP2012532323A (en) * 2009-06-30 2012-12-13 ライフスキャン・インコーポレイテッド Analyte testing method and system
EP2455875A3 (en) * 2009-06-30 2013-01-16 Lifescan Scotland Limited System and method for diabetes management
WO2011008520A2 (en) * 2009-06-30 2011-01-20 Lifescan, Inc. Analyte testing methods and device for calculating basal insulin therapy
JP5657678B2 (en) * 2009-09-29 2015-01-21 ライフスキャン・スコットランド・リミテッドＬｉｆｅＳｃａｎ Ｓｃｏｔｌａｎｄ， Ｌｔｄ． Analyte testing method and device for diabetes management
WO2011041531A1 (en) 2009-09-30 2011-04-07 Abbott Diabetes Care Inc. Interconnect for on-body analyte monitoring device
WO2011084208A1 (en) * 2009-12-21 2011-07-14 Stc.Unm System and methods for estimating hba1c, treatment response, and hypoglycemia risk using self-monitoring of blood glucose data
US9563743B2 (en) * 2010-02-25 2017-02-07 Lifescan Scotland Limited Analyte testing method and system with high and low blood glucose trends notification
US8532933B2 (en) 2010-06-18 2013-09-10 Roche Diagnostics Operations, Inc. Insulin optimization systems and testing methods with adjusted exit criterion accounting for system noise associated with biomarkers
US20120173151A1 (en) 2010-12-29 2012-07-05 Roche Diagnostics Operations, Inc. Methods of assessing diabetes treatment protocols based on protocol complexity levels and patient proficiency levels
EP2486851B8 (en) * 2011-01-31 2023-11-01 Roche Diabetes Care GmbH Display for biological values
US10136845B2 (en) 2011-02-28 2018-11-27 Abbott Diabetes Care Inc. Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same
US8766803B2 (en) 2011-05-13 2014-07-01 Roche Diagnostics Operations, Inc. Dynamic data collection
US8755938B2 (en) 2011-05-13 2014-06-17 Roche Diagnostics Operations, Inc. Systems and methods for handling unacceptable values in structured collection protocols
EP2756303B1 (en) * 2011-09-15 2018-08-22 The Trustees of Columbia University in the City of New York Measurement of a fluorescent analyte using tissue excitation
US9317656B2 (en) 2011-11-23 2016-04-19 Abbott Diabetes Care Inc. Compatibility mechanisms for devices in a continuous analyte monitoring system and methods thereof
US9351670B2 (en) * 2012-12-31 2016-05-31 Abbott Diabetes Care Inc. Glycemic risk determination based on variability of glucose levels
US10383580B2 (en) * 2012-12-31 2019-08-20 Abbott Diabetes Care Inc. Analysis of glucose median, variability, and hypoglycemia risk for therapy guidance
KR20180109980A (en) 2016-02-05 2018-10-08 아니마스 코포레이션 Visualization and analysis tools for drug delivery systems
JP6773602B2 (en) * 2017-05-09 2020-10-21 サニーヘルス株式会社 Diet support system
WO2019094908A1 (en) * 2017-11-13 2019-05-16 Senseonics, Incorporated Analyte monitoring system and method for determining system usage
CN112040841A (en) * 2018-04-18 2020-12-04 赞思健康科技有限公司 Metabolism monitoring system
JP2023518762A (en) * 2020-03-20 2023-05-08 ウェルドック インコーポレイテッド Systems and methods for analyzing, interpreting, and acting on continuous blood glucose monitoring data

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5822715A (en) * 1997-01-10 1998-10-13 Health Hero Network Diabetes management system and method for controlling blood glucose
US6175752B1 (en) * 1998-04-30 2001-01-16 Therasense, Inc. Analyte monitoring device and methods of use
US6233471B1 (en) * 1998-05-13 2001-05-15 Cygnus, Inc. Signal processing for measurement of physiological analysis
US6572542B1 (en) * 2000-03-03 2003-06-03 Medtronic, Inc. System and method for monitoring and controlling the glycemic state of a patient
US20060094947A1 (en) * 2000-03-29 2006-05-04 Kovatchev Boris P Method, system, and computer program product for the evaluation of glycemic control in diabetes from self-monitoring data

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010011224A1 (en) * 1995-06-07 2001-08-02 Stephen James Brown Modular microprocessor-based health monitoring system
WO1999062919A1 (en) * 1998-06-01 1999-12-09 Roche Diagnostics Corporation Redox reversible bipyridyl osmium complex conjugates
JP2000060803A (en) * 1998-08-21 2000-02-29 Terumo Corp Blood sugar level information processing system
US6427088B1 (en) * 2000-01-21 2002-07-30 Medtronic Minimed, Inc. Ambulatory medical apparatus and method using telemetry system with predefined reception listening periods
US20030060765A1 (en) * 2000-02-16 2003-03-27 Arthur Campbell Infusion device menu structure and method of using the same
US7022072B2 (en) * 2001-12-27 2006-04-04 Medtronic Minimed, Inc. System for monitoring physiological characteristics
EP1869598A2 (en) 2004-12-17 2007-12-26 Bayer Healthcare, LLC Device having a trend-indicating display

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5822715A (en) * 1997-01-10 1998-10-13 Health Hero Network Diabetes management system and method for controlling blood glucose
US6175752B1 (en) * 1998-04-30 2001-01-16 Therasense, Inc. Analyte monitoring device and methods of use
US6233471B1 (en) * 1998-05-13 2001-05-15 Cygnus, Inc. Signal processing for measurement of physiological analysis
US6572542B1 (en) * 2000-03-03 2003-06-03 Medtronic, Inc. System and method for monitoring and controlling the glycemic state of a patient
US20060094947A1 (en) * 2000-03-29 2006-05-04 Kovatchev Boris P Method, system, and computer program product for the evaluation of glycemic control in diabetes from self-monitoring data

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP2087356A4 *

Also Published As

Publication number Publication date
US8079955B2 (en) 2011-12-20
JP2010510866A (en) 2010-04-08
US20080125636A1 (en) 2008-05-29
EP2087356A2 (en) 2009-08-12
CA2670414A1 (en) 2008-06-05
EP2087356A4 (en) 2013-09-25
WO2008067291A2 (en) 2008-06-05

Similar Documents

Publication Publication Date Title
WO2008067291A3 (en) Method and apparatus for managing glucose control
PL2207582T3 (en) System and method for monitoring and regulating blood glucose levels
WO2007086071A3 (en) Apparatus, system and method for determining cardio-respiratory state
PT1949285T (en) Systems and methods for treating, diagnosing and predicting the occurrence of a medical condition
WO2008008899A3 (en) Methods and systems for compliance confirmation and incentives
EP2708899A3 (en) Methods and biomarkers for diagnosing and monitoring psychotic disorders
EP2066077A4 (en) System, device and method for controlling the carry change
WO2008082987A3 (en) Analyte meter protectors and methods
WO2007127005A3 (en) Methods and systems for monitoring sterilization status
PT2145276T (en) Systems and methods for treating, diagnosing and predicting the occurrence of a medical condition
EP2124508A4 (en) Audio visual environment control device, audio visual environment control system and audio visual environment control method
EP2115366A4 (en) Refrigerator and control method for the same
PT2332087T (en) Systems and methods of treating, diagnosing and predicting the occurrence of a medical condition
TWI348129B (en) Disorder detection device, disorder detection method and disorder detection program
EP2064488A4 (en) Substrates, systems and methods for analyzing materials
EP2101313A4 (en) Display control device, display control method, and program
EP2020493A4 (en) Variable valve-actuating device, control method for the device, and vehicle carrying the device
EP2006813A4 (en) Display device, data processing method and data processing system using the display device
EP2100453A4 (en) Monitoring system, monitoring method and program
EP2103635A4 (en) Oil-repellent copolymer, method for producing the same and oil-repellent processing liquid
EP1980943A4 (en) System monitor device control method, program, and computer system
EP1848326A4 (en) System, method and apparatus for measuring blood flow and blood volume
EP2012266A4 (en) Method and system for making risk monitoring on the online service
EP2047391A4 (en) Internet method, process and system for publication and evaluation
EP2051436A4 (en) The method, device and system for access authenticating

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07868857

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2007868857

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2670414

Country of ref document: CA

ENP Entry into the national phase

Ref document number: 2009539439

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE